View in EDS

Reply to: Comments on "Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)".

Saved in:
Bibliographic Details
Title: Reply to: Comments on "Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)".
Authors: Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain.; ARON Research Foundation ETS, Macerata, Italy., Roviello G; ARON Research Foundation ETS, Macerata, Italy.; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy., Fiala O; ARON Research Foundation ETS, Macerata, Italy.; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Taha T; ARON Research Foundation ETS, Macerata, Italy.; Royal Marsden NHS Foundation Trust, London, UK., Buti S; ARON Research Foundation ETS, Macerata, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy., Rizzo M; ARON Research Foundation ETS, Macerata, Italy.; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari, Bari, Italy., Massari F; ARON Research Foundation ETS, Macerata, Italy.; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Monteiro FSM; ARON Research Foundation ETS, Macerata, Italy.; Oncology and Hematology Department, Hospital Sírio Libanês, Brasília, Brazil., Santoni M; ARON Research Foundation ETS, Macerata, Italy.; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.
Source: International journal of cancer [Int J Cancer] 2026 Apr 01; Vol. 158 (7), pp. 1992-1994. Date of Electronic Publication: 2025 Dec 16.
Publication Type: Letter
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41400215
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reply to: Comments on "Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)".
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Molina-Cerrillo+J%22">Molina-Cerrillo J</searchLink>; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain.; ARON Research Foundation ETS, Macerata, Italy.<br /><searchLink fieldCode="AU" term="%22Roviello+G%22">Roviello G</searchLink>; ARON Research Foundation ETS, Macerata, Italy.; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Fiala+O%22">Fiala O</searchLink>; ARON Research Foundation ETS, Macerata, Italy.; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Taha+T%22">Taha T</searchLink>; ARON Research Foundation ETS, Macerata, Italy.; Royal Marsden NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Buti+S%22">Buti S</searchLink>; ARON Research Foundation ETS, Macerata, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Rizzo+M%22">Rizzo M</searchLink>; ARON Research Foundation ETS, Macerata, Italy.; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Massari+F%22">Massari F</searchLink>; ARON Research Foundation ETS, Macerata, Italy.; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Monteiro+FSM%22">Monteiro FSM</searchLink>; ARON Research Foundation ETS, Macerata, Italy.; Oncology and Hematology Department, Hospital Sírio Libanês, Brasília, Brazil.<br /><searchLink fieldCode="AU" term="%22Santoni+M%22">Santoni M</searchLink>; ARON Research Foundation ETS, Macerata, Italy.; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220042124%22">International journal of cancer</searchLink> [Int J Cancer] 2026 Apr 01; Vol. 158 (7), pp. 1992-1994. <i>Date of Electronic Publication: </i>2025 Dec 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0042124 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200207136%22">00207136 </searchLink><i>NLM ISO Abbreviation: </i>Int J Cancer <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41400215
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ijc.70289
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1992
    Titles:
      – TitleFull: Reply to: Comments on "Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)".
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Molina-Cerrillo J
      – PersonEntity:
          Name:
            NameFull: Roviello G
      – PersonEntity:
          Name:
            NameFull: Fiala O
      – PersonEntity:
          Name:
            NameFull: Taha T
      – PersonEntity:
          Name:
            NameFull: Buti S
      – PersonEntity:
          Name:
            NameFull: Rizzo M
      – PersonEntity:
          Name:
            NameFull: Massari F
      – PersonEntity:
          Name:
            NameFull: Monteiro FSM
      – PersonEntity:
          Name:
            NameFull: Santoni M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0215
          Numbering:
            – Type: volume
              Value: 158
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: International journal of cancer
              Type: main
ResultId 1